International survey on the impact of parasitic infections: frequency of transmission and current mitigation strategies

Vox Sanguinis

Volumn 114, Issue 1, 2019, Pages 17-27

  Leiby, David A ^a   O'Brien, Sheila F ^b   Wendel, Silvano ^c   Nguyen, Megan L ^d   Delage, Gilles ^e   Devare, Sushil G ^f   Hardiman, Anthony ^g   Nakhasi, Hira L ^a   Sauleda, Silvia ^h   Bloch, Evan M ⁱ  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CANADIAN BLOOD SERVICES   (Canada)

^c HOSPITAL SÍRIO LIBANÊS   (Brazil)

^d HOLLAND LABORATORY   (United States)

^e HÉMA QUÉBEC   (Canada)

^f Abbott Diagnostics   (United States)

^g ROCHE MOLECULAR SYSTEMS   (United States)

^h BANC DE SANG I TEIXITS   (Spain)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Babesia; Leishmania; Plasmodium; public health; transfusion transmission; Trypanosoma cruzi

Indexed keywords

ARTICLE; AUSTRALIA; BELGIUM; BLOOD SAFETY; BRAZIL; CANADA; CHAGAS DISEASE; ENGLAND; FRANCE; HEALTH CARE SURVEY; HONDURAS; HUMAN; IRELAND; ISRAEL; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALARIA; MEXICO; NEW ZEALAND; NORWAY; PARASITE TRANSMISSION; PARASITOSIS; PIROPLASMOSIS; POLAND; PORTUGAL; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RUSSIAN FEDERATION; SOUTH AFRICA; SPAIN; UNITED STATES; WALES; ANIMAL; BLOOD TRANSFUSION REACTION; DISEASE TRANSMISSION; PREVENTION AND CONTROL; PROTOZOAL INFECTION; QUESTIONNAIRE; STANDARDS; STATISTICS AND NUMERICAL DATA; TRANSMISSION;

ANIMALS; BLOOD SAFETY; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; PROTOZOAN INFECTIONS; SURVEYS AND QUESTIONNAIRES; TRANSFUSION REACTION;

EID: 85058040106     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12727     Document Type: Article

References (32)

1. O'Brien SF, Yi QL, Fan W, et al.: Residual risk of HIV, HCV and HBV in Canada. Transfus Apher Sci 2017; 56:389–391
2. Dodd RY, Foster GA, Stramer SL: Keeping blood transfusion safe from West Nile virus: American Red Cross Experience, 2003 to 2012. Transfus Med Rev 2015; 29:153–161
3. World Health Organization. World Malaria Report 2016. Geneva: World Health Organiztion; 2016. Available from: URL: http://www.who.int/malaria/publications/world-malaria-report-2016/report/en/.
4. O'Brien SF, Delage G, Seed CR, et al.: The epidemiology of imported malaria and transfusion policy in 5 nonendemic countries. Transfus Med Rev 2015; 29:162–171
5. Schmunis GA, Yadon ZE: Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 2010; 115:14–21
6. Herwaldt BL, Linden JV, Bosserman E, et al.: Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011; 155:509–519
7. Moritz ED, Winton CS, Tonnetti L, et al.: Screening for Babesia microti in the U.S. Blood Supply. N Eng J Med 2016; 375:2236–2245
8. Bullard JM, Ahsanuddin AN, Perry AM, et al.: The first case of locally acquired tick-borne Babesia microti infection in Canada. Can J Infect Dis Med Microbiol 2014; 25:e87–e89
9. Jiang JF, Zheng YC, Jiang RR, et al.: Epidemiological, clinical, and laboratory characteristics of 48 cases of “Babesia venatorum” infection in China: a descriptive study. Lancet Infect Dis 2015; 15:196–203
10. Morch K, Holmaas G, Frolander PS, et al.: Severe human Babesia divergens infection in Norway. Int J Infect Dis 2015; 33:37–38
11. Du R, Hotez PJ, Al-Salem WS, et al.: Old world cutaneous leishmaniasis and refugee crises in the Middle East and North Africa. PLoS Negl Trop Dis 2016; 10:e0004545
12. Petersen LR, Jamieson DJ, Honein MA: Zika Virus. N Eng J Med 2016; 375:294–295
13. Moritz ED, Winton CS, Johnson ST, et al.: Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States. Transfusion 2014; 54:2226–2236
14. EDQM. Guide to the preparation, use, and quality assurance of blood components. 19th edn. Strasbourg, France: EDQM, 2017.
15. JPAC Donor selection guidelines. http://www.transfusionguidelines.org/dsg/wb/guidelines/ma001-malaria (Accessed August 23, 2017).
16. Mansueto P, Seidita A, Vitale G, et al.: Transfusion transmitted leishmaniasis. What to do with blood donors from endemic areas?. Travel Med Infect Dis 2014; 12:617–627
17. Jimenez-Marco T, Fisa R, Girona-Llobera E, et al.: Transfusion-transmitted leishmaniasis: a practical review. Transfusion 2016; 56(Suppl 1):S45–S51
18. Hildebrandt A, Hunfeld KP, Baier M, et al.: First confirmed autochthonous case of human Babesia microti infection in Europe. Eur J Clin Microbiol Infect Dis 2007; 26:595–601
19. Matsui T, Inoue R, Kajimoto K, et al.: [First documentation of transfusion-associated babesiosis in Japan]. Rinsho Ketsueki 2000; 41:628–634
20. Martin DL, Goodhew B, Czaicki N, et al.: Trypanosoma cruzi survival following cold storage: possible implications for tissue banking. PLoS ONE 2014; 9:e95398
21. Yasukawa K: Blood donor screening for Trypanosoma cruzi infection in Japan. Transfusion 2014; 54:745–746
22. Niederhauser C, Gottschalk J, Tinguely C: Selective testing of at-risk blood donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland. Transfus Med Hemother 2016; 43:169–176
23. Slot E, Hogema BM, Molier M, et al.: Risk factors and screening for Trypanosoma cruzi infection of Dutch blood donors. PLoS ONE 2016; 11:e0151038
24. Kleinman S, Stassinopoulos A: Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation. Transfusion 2015; 55:2983–3000
25. Castro E, Girones N, Bueno JL, et al.: The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets. Transfusion 2007; 47:434–441
26. Grellier P, Benach J, Labaied M, et al.: Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components. Transfusion 2008; 48:1676–1684
27. Tonnetti L, Thorp AM, Reddy HL, et al.: Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light. Transfusion 2015; 55:326–329
28. Tonnetti L, Thorp AM, Reddy HL, et al.: Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Transfusion 2012; 52:409–416
29. Jimenez-Marco T, Cancino-Faure B, Girona-Llobera E, et al.: The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole blood. Transfusion 2017; 57:1440–1447
30. Allain JP, Owusu-Ofori AK, Assennato SM, et al.: Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial. Lancet 2016; 387:1753–1761
31. Ware AD, Jacquot C, Tobian AAR, et al.: Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings. Vox Sang 2018; 113:3–12
32. O'Brien S, Ward S, Seed C, et al.: A retrospective comparison of malaria policy formulation in 5 non-endemic countries [abstract]. Vox Sang 2018; 113(Suppl. 1):30